SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-22-026574
Filing Date
2022-09-22
Accepted
2022-09-22 17:00:11
Documents
5
Period of Report
2022-09-22

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 375233
2 proxy_001.jpg GRAPHIC 327313
3 proxy_002.jpg GRAPHIC 177203
4 proxy_003.jpg GRAPHIC 351264
5 proxy_004.jpg GRAPHIC 249018
  Complete submission text file 0001493152-22-026574.txt   1808216
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38022 | Film No.: 221259958
SIC: 2834 Pharmaceutical Preparations